THE SIGNIFICANCE OF ALK REARRANGEMENT IN SELECTED ADVANCED NON-SMALL CELL LUNG CANCER: ALK EXPRESSION PROVIDES INSIGHTS INTO ALK TARGET THERAPY

被引：0
|
作者：
Zhang, Ningning [1 ,2 ]
Shi, Yuankai [1 ,2 ]
Ma, Li [1 ,2 ]
Hao, Xuezhi [1 ,2 ]
Lin, Dongmei [2 ,3 ]
Han, Xiaohong [1 ,2 ]
Liu, Yutao [1 ,2 ]
Wang, Lin [1 ,2 ]
Yuan, Zheng [2 ,3 ]
Yang, Sheng [1 ,2 ]
机构：
[1] Chinese Acad Med Sci, Canc Inst Hosp, Beijing Key Lab Clin Study Anticanc Mol Targeted, Beijing, Peoples R China
[2] Peking Union Med Coll, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Canc Inst Hosp, Dept Pathol, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2013年 / 8卷
关键词：
Alk rearrangement; non-small cell lung cancer; ALK expression; Crizotinib;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.11-038
引用
收藏
页码：S612 / S612
页数：1
相关论文
共 50 条
  • [21] ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer
    Mota, Ines
    Patrucco, Enrico
    Mastini, Cristina
    Mahadevan, Navin R.
    Thai, Tran C.
    Bergaggio, Elisa
    Cheong, Taek-Chin
    Leonardi, Giulia
    Karaca-Atabay, Elif
    Campisi, Marco
    Poggio, Teresa
    Menotti, Matteo
    Ambrogio, Chiara
    Longo, Dario L.
    Klaeger, Susan
    Keshishian, Hasmik
    Sztupinszki, Zsofia M.
    Szallasi, Zoltan
    Keskin, Derin B.
    Duke-Cohan, Jonathan S.
    Reinhold, Bruce
    Carr, Steven A.
    Wu, Catherine J.
    Moynihan, Kelly D.
    Irvine, Darrell J.
    Barbie, David A.
    Reinherz, Ellis L.
    Voena, Claudia
    Awad, Mark M.
    Blasco, Rafael B.
    Chiarle, Roberto
    NATURE CANCER, 2023, 4 (07) : 1016 - +
  • [22] Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer
    Kang, Jin
    Zhang, Xu-Chao
    Chen, Hua-Jun
    Zhong, Wen-Zhao
    Xu, Yang
    Su, Jian
    Zhou, Qing
    Tu, Hai-Yan
    Wang, Zhen
    Xu, Chong-Rui
    Yang, Xue-Ning
    Chen, Zhi-Hong
    Wu, Xue
    Zhang, Xian
    Shao, Yang
    Wu, Yi-Long
    Yang, Jin-Ji
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [23] Cardiac Toxicity of Crizotinib Therapy in Advanced ALK-Rearranged Non-Small Cell Lung Cancer
    Zhang, Yan
    Wang, Yan
    Li, Junling
    Hao, Xuezhi
    Ma, Di
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S377 - S377
  • [24] The emerging role of ALK inhibitors in the treatment of advanced non-small cell lung cancer
    Galetta, Domenico
    Rossi, Antonio
    Pisconti, Salvatore
    Colucci, Giuseppe
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 : S45 - S54
  • [25] The analysis of ALK gene rearrangement by fluorescence in situ hybridization in non-small cell lung cancer patients
    Wojas-Krawczyk, Kamila
    Krawczyk, Pawel Adam
    Ramlau, Rodryg Adam
    Szumilo, Justyna
    Kozielski, Jerzy
    Kalinka-Warzochas, Ewa
    Bryl, Maciej
    Knopik-Nabrowicz, Alina
    Spychalski, Lukasz
    Szczesna, Aleksandra
    Rydzik, Ewelina
    Milanowski, Janusz
    WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2013, 17 (06): : 484 - 492
  • [26] Differential protein stability and clinical responses of EML4-ALK fusion variants to various ALK inhibitors in advanced ALK-rearranged non-small cell lung cancer
    Woo, C. G.
    Seo, S.
    Kim, S. W.
    Jang, S. J.
    Park, K. S.
    Song, J. Y.
    Lee, B.
    Richards, M. W.
    Bayliss, R.
    Lee, D. H.
    Choi, J.
    ANNALS OF ONCOLOGY, 2017, 28 (04) : 791 - 797
  • [27] Native and Rearranged ALK Copy Number and Rearranged Cell Count in Non-Small Cell Lung Cancer Implications for ALK Inhibitor Therapy
    Camidge, D. Ross
    Skokan, Margaret
    Kiatsimkul, Porntip
    Helfrich, Barbara
    Lu, Xian
    Baron, Anna E.
    Schulte, Nathan
    Maxson, DeLee
    Aisner, Dara L.
    Franklin, Wilbur A.
    Doebele, Robert C.
    Varella-Garcia, Marileila
    CANCER, 2013, 119 (22) : 3968 - 3975
  • [28] CUX1-ALK: A Novel ALK Rearrangement That Responds to Crizotinib in Non-Small-Cell Lung Cancer
    Zhang, M.
    Wang, Q.
    Ding, Y.
    Wang, G.
    Chu, Y.
    He, X.
    Wu, X.
    Shao, Y. W.
    Lu, K.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S800 - S800
  • [29] Anti-Angiogenic Therapy in ALK Rearranged Non-Small Cell Lung Cancer (NSCLC)
    Tan, Aaron C.
    Pavlakis, Nick
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (16)
  • [30] STK3-ALK, a Novel ALK Rearrangement in Non-Small Cell Lung Cancer With Sensitivity to Tyrosine Kinase Inhibitors: A Case Report
    Feng, Chunlai
    Zhou, Rong
    Liu, Feng
    Wang, Tingting
    Liu, Sisi
    Shao, Yang
    FRONTIERS IN ONCOLOGY, 2021, 11
12345